MedPath

A Randamized, Prospective and Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma

Not Applicable
Conditions
veitic Glaucoma
Registration Number
JPRN-UMIN000007820
Lead Sponsor
Deportment of Ophthalmology, University of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1) herpetic iritis 2) PAS index>25% (secondary angle closure glaucoma) 3) The patients who received Argon Laser Trabeculoplasty within 3 months. 4) The patients who received intraocular surgeries within 6 months. 5)The patients who had asthma or arrythmia, and couldn't receive timolol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath